The problem
Respiratory viral infections may cause Pulmonary fibrosis.
COVID-19: Multi-organ injuries may cause scarring / fibrosis in
lungs, heart, kidneys and liver.
​
"Hypertrophic" dermal scars after surgery & burns can be a stigma,
a burden or even a physical handicap with reduced mobility of joints.
Severe or unattractive dermal scars are also reported
after surgery in up to one third of Caucasians and
two thirds of Chinese and Polynesians.
​​
Other potential indications:
Scarring and adhesions in body cavities after
-
hip or knee replacement
-
back surgery (spinal laminectomy)
-
abdominal surgery
-
gynecological surgery
​​
Our innovation
Cellastra is pioneering two potentially revolutionary treatments:
-
FIBREXA - inhaled after respiratory infections such as Influenza, RSV and
COVID-19.
-
SCARLEXA - applied under the skin or intramuscular after surgery.
These two gene vectors delivers the genetic code to the wound area:
-
To enable robust production of an antiscarring peptide for several weeks
-
To promote scarless wound healing.
​
